Clinical Supply Regulatory Articles
-
When Drug Supply Has A Half-Life: Radiopharmaceutical Logistics
10/1/2026
Radiopharmaceuticals turn time into a supply-chain constraint. Short half-lives, patient scheduling, scarce radionuclides and regulatory differences reshape trial logistics.
-
Segregation Of Duties: Drug Accountability Needs Three Separate Roles
9/28/2026
When one person orders, receives, and reconciles investigational product, a critical control disappears. See how role separation can strengthen drug accountability.
-
Before The Excursion: The Governance Decisions That Should Already Be Made
9/24/2026
Temperature excursions are inevitable. The real risk is the time lost deciding what to do. See how preplanned governance can turn long quarantines into routine events.
-
The Reliance Trap: When Regulatory Strategy Becomes A Clinical Supply Problem
9/17/2026
The wrong regulatory filing sequence can close faster pathways, delay importation, and consume shelf life. Here’s how regulatory strategy can reshape clinical supply.
-
CSM Feasibility Begins With Research Strategy And Study Design
9/15/2026
Study design decisions can create costly clinical supply problems months later. Early CSM review can expose hidden requirements before they become delays, waste, and rework.
-
Clinical Supply Systems Need IT General Controls
9/14/2026
Validating a clinical trial system does not prove it stays trustworthy. IT general controls can protect data, supply decisions and patient safety long after go-live.
-
Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
9/4/2026
Clinical Supply Leader expands its Editorial Advisory Board expertise with the addition of Éamonn McArdle (Allergy Therapeutics) and Juan Hernandez (Bensen Solutions).
-
CDMO Quality Oversight: How FDA And Pharma Leaders Are Rethinking Data, AI, And Culture
9/2/2026
Discover strategies for risk-based governance, AI-enabled quality management, stronger collaboration, and fostering a culture that supports long-term operational excellence.
-
Managing Customs, Import/Export Requirements, And Cross-Border Logistics Challenges
8/10/2026
Customs delays can derail clinical trials in days. Learn practical strategies for import compliance, digital preclearance, and resilient cross-border logistics.
-
July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing
8/7/2026
Mathini Ilancheran updates us on how delayed U.S. tariffs on generic drug imports could reshape supply, sourcing, and trial planning.